Keywords: glenmark, pretax, profits, rise, india, pharmaceuticals, posted
Glenmark pretax profits rise 54%
Article | 04 February 2002
India's Glenmark Pharmaceuticals has posted a 47% sales increase for thethird quarter ended December 2001 to 750.1 million rupees ($15.5 million). Pretax profits rose 54% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
